Lawrence Erik Kurzius Acquires 2,000 Shares of Cooper Companies (NASDAQ:COO) Stock

Key Points

• Director Lawrence Erik Kurzius acquired 2,000 shares of Cooper Companies (NASDAQ: COO) at $68.39 per share, increasing his ownership by 52.95% to a total of 5,777 shares, valued at approximately $395,089.03.
• Cooper Companies reported a Q3 earnings per share (EPS) of $1.10, surpassing expectations and showing a 5.7% revenue increase compared to the previous year.
• The company has initiated a stock buyback program allowing for the repurchase of $2.00 billion worth of shares, indicating confidence in the stock's valuation.

The Cooper Companies, Inc. (NASDAQ:COO - Get Free Report) Director Lawrence Erik Kurzius bought 2,000 shares of the firm's stock in a transaction on Monday, September 29th. The stock was acquired at an average cost of $68.39 per share, for a total transaction of $136,780.00. Following the completion of the purchase, the director directly owned 5,777 shares in the company, valued at approximately $395,089.03. This represents a 52.95% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Cooper Companies Trading Up 0.2%

Shares of COO stock traded up $0.12 during trading on Monday, hitting $67.67. 1,995,234 shares of the stock traded hands, compared to its average volume of 2,852,506. The firm has a market capitalization of $13.45 billion, a P/E ratio of 33.34, a price-to-earnings-growth ratio of 1.77 and a beta of 0.97. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.12 and a quick ratio of 1.24. The firm's fifty day moving average price is $70.06 and its 200-day moving average price is $74.38. The Cooper Companies, Inc. has a 52-week low of $61.78 and a 52-week high of $110.68.

Cooper Companies (NASDAQ:COO - Get Free Report) last released its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 EPS for the quarter, beating the consensus estimate of $1.07 by $0.03. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The firm had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.06 billion. During the same quarter in the previous year, the company earned $0.96 EPS. The business's revenue for the quarter was up 5.7% compared to the same quarter last year. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, research analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies declared that its board has approved a stock buyback program on Wednesday, September 17th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the medical device company to reacquire up to 15.4% of its stock through open market purchases. Stock repurchase programs are usually an indication that the company's leadership believes its stock is undervalued.

Institutional Investors Weigh In On Cooper Companies

Institutional investors and hedge funds have recently bought and sold shares of the stock. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Cooper Companies by 15.1% in the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 26,189 shares of the medical device company's stock valued at $2,194,000 after buying an additional 3,440 shares during the last quarter. DAVENPORT & Co LLC increased its stake in shares of Cooper Companies by 13.4% during the first quarter. DAVENPORT & Co LLC now owns 4,335 shares of the medical device company's stock worth $366,000 after acquiring an additional 513 shares during the period. Cerity Partners LLC increased its stake in shares of Cooper Companies by 6.6% during the first quarter. Cerity Partners LLC now owns 17,113 shares of the medical device company's stock worth $1,443,000 after acquiring an additional 1,054 shares during the period. State of Alaska Department of Revenue increased its stake in shares of Cooper Companies by 3.0% during the first quarter. State of Alaska Department of Revenue now owns 23,390 shares of the medical device company's stock worth $1,972,000 after acquiring an additional 680 shares during the period. Finally, United Services Automobile Association acquired a new position in shares of Cooper Companies during the first quarter worth about $414,000. 24.39% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

COO has been the subject of several recent analyst reports. JPMorgan Chase & Co. decreased their price objective on shares of Cooper Companies from $76.00 to $66.00 and set a "neutral" rating for the company in a research report on Thursday, August 28th. BNP Paribas Exane raised shares of Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 price objective for the company in a research report on Tuesday, July 22nd. UBS Group raised shares of Cooper Companies to a "buy" rating in a research report on Tuesday, June 17th. Stifel Nicolaus decreased their price objective on shares of Cooper Companies from $90.00 to $85.00 and set a "buy" rating for the company in a research report on Thursday, August 28th. Finally, Morgan Stanley set a $76.00 price objective on shares of Cooper Companies and gave the stock an "equal weight" rating in a research report on Thursday, August 28th. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $86.64.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.